1-20 of 93
Tsila Zuckerman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Second Infusion of CAR T-Cells in Patients with Relapsed /Refractory B-Cell Acute Lymphoblastic Leukemia: Results from a Gocart Coalition Analysis on Behalf of the PDWP, ALWP, and Ctiwp of the EBMT

Susana Rives, Giorgio Ottaviano, Nuria Martínez-Cibrián, Shatha Y. Farhan, Sowjanya Vuyyala, Jacques-Emmanuel Galimard, Eva Michel, Fizza Imran, Nazaret Sánchez-Sierra, Richard Mitchell, Stephan Mielke, Andishe Attarbaschi, Soeren Lykke Petersen, Samppa Ryhanen, Sr., Wolfgang Andreas Bethge, David Beauvais, Tsila Zuckerman, Antonio Pérez-Martínez, Krzysztof Kalwak, Fabio Ciceri, Annalisa Ruggeri, Julio Delgado, Sebastian Giebel, Adriana Balduzzi, Anna Alonso-Saladrigues, Valentin Ortiz-Maldonado
Journal: Blood
Blood (2024) 144 (Supplement 1): 965.
https://doi.org/10.1182/blood-2024-205669
Published: 2024
Journal Articles

Optical Genome Mapping Reclassifies Patients with Intermediate Risk Acute Myeloid Leukemia

Baher Krayem, Nivin moustafa-Hawash, Avraham Frisch, Christina Srouji, Tsila Zuckerman
Journal: Blood
Blood (2024) 144 (Supplement 1): 1559.
https://doi.org/10.1182/blood-2024-206768
Published: 2024
Journal Articles

Comparable Outcomes of Point-of-Care and Commercial CD19 CAR-T Therapies: A Patient-Matched Analysis in Large B-Cell Lymphoma

Ronit Marcus, Abraham Avigdor, Uri Greenbaum, Noa Golan Accav, Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Elad Jacoby, Arnon Nagler, Avichai Shimoni, Annamaria Ballweg, Xavier Deschênes-Simard, Efrat Luttwak, Gunjan L. Shah, Michael Scordo, Parastoo B Dahi, Miguel Angel Perales, Tsila Zuckerman, Israel Henig, Dana Yehudai-Ofir, Hazim Khatib, Roni Shouval, Ofrat Beyar Katz
Journal: Blood
Blood (2024) 144 (Supplement 1): 608.
https://doi.org/10.1182/blood-2024-207638
Published: 2024
Journal Articles

The Ability of Currently Used Scoring Systems to Predict 30 and 100-Days Non-Relapse Mortality Among Older Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Amir Tafesh, Dana Yehudai-Ofir, Ofrat Beyar-Katz, Hazim Khatib, Baher Krayem, Avraham Frisch, Tsila Zuckerman, Israel Henig
Journal: Blood
Blood (2024) 144 (Supplement 1): 3482.
https://doi.org/10.1182/blood-2024-194308
Published: 2024
Journal Articles

Belumosudil Is Efficacious for the Management of Heavily Pretreated and Prolonged Chronic Graft-Versus-Host Disease: A Retrospective Multi-Center Real-World Study By the Israel Association for Bone Marrow Transplantation and Cellular Therapy

Ben Varon, Ron Ram, Avichai Shimoni, Batia Avni, Sigal Grisariu, Vered Stavi, Yael Bar-On, Moshe Yeshurun, Ronit Elhasid, Aharon Gefen, Asaf Yanir, Odelia Amit, Dana Yehudai-Ofir, Israel Henig, Tsila Zuckerman
Journal: Blood
Blood (2024) 144 (Supplement 1): 7338.
https://doi.org/10.1182/blood-2024-206874
Published: 2024
Journal Articles

CD19 CAR-T Cell Therapy Is Effective in Richter Transformation: A Multicenter Retrospective Analysis By the European Research Initiative on Chronic Lymphocytic Leukemia

Ofrat Beyar-Katz, Ohad Benjamini, Julio Delgado, Marco Ruella, Ron Ram, Sigal Grisariu, Andrea Visentin, Elisabeth Vandenberghe, Massimo Gentile, Abraham Avigdor, Avichai Shimoni, Roni Shouval, Ronit Marcus, Stephen J. Schuster, Valentin Ortiz-Maldonado, Guido Ghilardi, Luca Paruzzo, Tsila Zuckerman, Tamar Tadmor, Riva Fineman, Odelia Amit, Nuria Martinez-Cibrian, Giulia Gabrielli, Batia Avni, Eva Minga, Noga Shem-Tov, Lydia Scarfo, Ronit Yerushalmi, Arnon Nagler, Ronit Leiba, Ivetta Danylesko, Kostas Stamatopoulos, Thomas Chatzikonstantinou, Paolo Ghia, Yair Herishanu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4504.
https://doi.org/10.1182/blood-2024-200050
Published: 2024
Journal Articles

CAR-Tography: Longitudinal Mapping of CAR-T Toxicities across B-Cell Malignancies Reveals Biologically Distinct and Prognostically Relevant Toxicity Phenotypes

Kai Rejeski, Teng Fei, Alejandro Luna, Mohammad Alhomoud, Yannis K. Valtis, Noriko Nishimura, Marina Gomez-Llobell, Noa Golan Accav, Ofrat Beyar-Katz, Sandeep S. Raj, Magdalena Corona, Alfredo Rivas-Delgado, Hamza Hashmi, Sridevi Rajeeve, Efrat Luttwak, Michael Scordo, Gunjan L. Shah, Maria Lia Palomba, Michael von Bergwelt-Baildon, Marion Subklewe, Abraham Avigdor, Ronit Marcus, Avichai Shimoni, Arnon Nagler, Tsila Zuckerman, Jabour Halloun, Uri Greenbaum, Sham Mailankody, Saad Z. Usmani, Gilles Salles, Jae H. Park, Miguel Angel Perales, Roni Shouval
Journal: Blood
Blood (2024) 144 (Supplement 1): 912.
https://doi.org/10.1182/blood-2024-203520
Published: 2024
Journal Articles

Reduction in Platelet Counts May Predict the Development of Immune Effector Cell Associated Neurotoxicity Syndrome in Patients Receiving CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma

Hazim Khatib, Amit Parizat, Jabour Halloun, Roni Shouval, Niveen Shibli, Onit Alalouf, Tsila Zuckerman, Nataly Vahaba, Iris Halamish, Danielle Sapir, Israel Henig, Dana Yehudai-Ofir, Shimrit Harlev, Netanel A. Horowitz, Noa Lavi, Nurit Horesh, Riva Fineman, Inna Tzoran, Tsofia Levi, Eldad J. Dann, Ahmad Mruwat, Benjamin Brenner, Ron Hoffman, Ayal Rozenberg, Yoav Shechtman, Ofrat Beyar-Katz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1748.
https://doi.org/10.1182/blood-2024-202937
Published: 2024
Journal Articles

Impact of Broad-Spectrum Antibiotic Exposure on CAR-T Therapy Outcomes in B-Cell Lymphoma: A Multicenter International Study

Roni Shouval, Teng Fei, Giulia Gabrielli, Natalie Grier Smith, Guido Ghilardi, John Slingerland, Jonathan U. Peled, Ying Taur, Sunita D. Nasta, Alejandro Luna, Magdalena Corona, Kai Rejeski, Sophia Stock, Ronit Marcus, Noa Golan Accav, Ofrat Beyar-Katz, Hazim Khatib, Sandeep S. Raj, Alexander P. Boardman, Parastoo B Dahi, Richard J. Lin, Michael Scordo, Lorenzo Falchi, Jakub Svoboda, Elise A. Chong, Stefan K. Barta, Daniel J. Landsburg, Avichai Shimoni, Arnon Nagler, Gunjan L. Shah, Maria Lia Palomba, Gilles Salles, Jae H. Park, Stephen J. Schuster, Tsila Zuckerman, Marion Subklewe, Abraham Avigdor, Miguel Angel Perales, Marcel R.M. van den Brink, Marco Ruella
Journal: Blood
Blood (2024) 144 (Supplement 1): 1746.
https://doi.org/10.1182/blood-2024-203871
Published: 2024
Journal Articles

For Patients with Adverse-Risk Acute Myeloid Leukemia, Frontline FLAG Ida with Venetoclax Is Safe and Efficacious

Baher Krayem, Avraham Frisch, Tsila Zuckerman, Israel Henig, Dana Yehudai-Ofir, Boaz Nachmias, Hazim Khatib, Arnon Haran, Shlomzion Aumann
Journal: Blood
Blood (2024) 144 (Supplement 1): 4269.
https://doi.org/10.1182/blood-2024-204627
Published: 2024
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan -Fludarabine and Busulfan-Fludarabine Conditioning Have Similar Efficacy in Patients ≥65 Years Old or Those with Comorbidities

Israel J. Henig, Ohad Geller, Dana Yehudai-Ofir, Baher Krayem, Avraham Frisch, Hazim Khatib, Tsila Zuckerman
Journal: Blood
Blood (2023) 142 (Supplement 1): 2166.
https://doi.org/10.1182/blood-2023-180721
Published: 2023
Journal Articles

AML Drug Tolerant Persister (DTP) Cells Survive Chemotherapy By Transiently Altering Cellular Lipidomics to Increase Plasma Membrane Rigidity, but Also Increases Sensitivity to Immune Cell Killing

Yael Morgenstern, JongBok Lee, Yoosu Na, William Gwynne, Rose Hurren, Li Ma, Marcela Gronda, Chaitra Sarathy, Arvind Mer, Andrea Arruda, Avraham Frisch, Tsila Zuckerman, Yishai Ofran, Mark D. Minden, Li Zhang, Catherine O'Brien, J. Rafael Montenegro-Burke, Aaron D. Schimmer
Journal: Blood
Blood (2023) 142 (Supplement 1): 2806.
https://doi.org/10.1182/blood-2023-178995
Published: 2023
Journal Articles

Second Vs Third Line Treatment with Axicabtagene Ciloleucel for Large B Cell Lymphoma - a Real-Life National Multicenter Retrospective Cohort Study with Propensity Score Matching

Gil Fridberg, Odelia Amit, Liat Shargian, Ofrat Beyar Katz, Sigal Grisariu, Chava Perry, Ronit Gurion, Batia Avni, Tsila Zuckerman, Irit Avivi Mazza, Ron Ram
Journal: Blood
Blood (2023) 142 (Supplement 1): 4886.
https://doi.org/10.1182/blood-2023-188473
Published: 2023
Journal Articles

The ELN 2022 Risk Stratification Has No Impact on the Dismal Prognosis of Patients with Acute Undifferentiated Leukemia

Baher Krayem, Tsila Zuckerman, Avraham Frisch, Ilana Slouzkey, Tehila Azoulay, Michal Karmona, Liran I. Shlush, Nathali Kaushansky, Noa Chapal-Ilani, Shimrit Ringelstein-Harlev
Journal: Blood
Blood (2023) 142 (Supplement 1): 4221.
https://doi.org/10.1182/blood-2023-188592
Published: 2023
Journal Articles

Soluble LAG3: A Potential Marker for the Development and Activity of Acute Graft-Versus-Host Disease

Dana Yehudai-Ofir, Nasren Eiza, Israel J. Henig, Tsila Zuckerman, Zahava Vadasz
Journal: Blood
Blood (2023) 142 (Supplement 1): 4795.
https://doi.org/10.1182/blood-2023-184496
Published: 2023
Journal Articles

Response Rates of Extra-Nodal Diffuse Large B Cell Lymphoma to CD19-CAR T Cells - a Real Word Retrospective Multi-Center Study

Ofrat Beyar Katz, Chava Perry, Efrat Luttwak, Inbal Sdayoor, Yael Bar-On, Odelia Amit, Ronit Gold, Yair Herishanu, Noam Benyamini, Sigal Grisariu Greenzaid, Batia Avni, Polina Stepensky, Diana Libster, Dana Yehudai-Ofir, Shimrit Harlev, Liat Sharvit, Tsila Zuckerman, Uri Greenbaum, Irit Avivi, Ron Ram
Journal: Blood
Blood (2022) 140 (Supplement 1): 3816–3817.
https://doi.org/10.1182/blood-2022-165149
Published: 2022
Journal Articles

PLX-R18 (Avoplacel), a Placental Expanded Mesenchymal-like Stromal Cell Therapy Shows Favorable Safety and Appears to Improve Incomplete Hematopoietic Recovery after Hematopoietic Cell Transplantation (HCT)

Hillard M Lazarus, Joseph P. McGuirk, Tsila Zuckerman, Leland Metheny, Luis Pineiro, Mark R. Litzow, Scott D. Rowley, Batia Avni, Roni Tamari, Michal Sheleg, Daniel Rothenstein, Nitsan Halevy, Jacob M. Rowe
Journal: Blood
Blood (2022) 140 (Supplement 1): 10447–10448.
https://doi.org/10.1182/blood-2022-169266
Published: 2022
Journal Articles

Clinical Predictors for Relapse Among Patients with AML Who Responded to Venetoclax-Based Treatment - a Real-World Prospective Analysis from the Revive Study Group

Chezi Ganzel, Yakir Moshe, Itai Levi, Boaz Nachmias, Sigal Tavor, Jonathan Canaani, Tsila Zuckerman, Doaa Okasha, Ilana Hellmann, Tamar Tadmor, Najib Dally, Galia Stemer, Raanan Cohen, Jenia Berelovich, Noa Rivlin, Neta Frankel, Moshe Grunspan, Keren Ofek, Yishai Ofran, Ofir Wolach
Journal: Blood
Blood (2022) 140 (Supplement 1): 9002–9004.
https://doi.org/10.1182/blood-2022-162140
Published: 2022
Journal Articles

Comparison of Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated with Venetoclax and Hypomethylating Agents Vs Other Therapies By TP53 and IDH1/2 Mutation: Results from the AML Real World Evidence (ARC) Initiative

Ofir Wolach, Jacqueline S. Garcia, Pinkal Desai, Pankit Vachhani, Joshua F. Zeidner, Sameem Abedin, Kendra Sweet, Catherine Lai, Yakir Moshe, Daniel A. Pollyea, Marin Xavier, Boaz Nachmias, Tsila Zuckerman, Sangmin Lee, Evan C. Chen, Srilakshmi Bathini, Wesleigh Edwards, Cat N. Bui, Wei-Han Cheng, Catherine Miller, Annie Guerin, Jessica Maitland, Esprit Ma, Melissa Montez, Moshe Grunspan, Aaron D Goldberg
Journal: Blood
Blood (2022) 140 (Supplement 1): 11026–11028.
https://doi.org/10.1182/blood-2022-159615
Published: 2022
Journal Articles

Chronic Graft Versus Host Disease Detected By Tissue-Specific Cell-Free DNA Methylation Biomarkers

Batia Avni, Daniel Neiman, Elior Shaked, Sigal Grisariu Greenzaid, Mona Kuzli, Andrea Fracchia, Polina Stepensky, Tsila Zuckerman, Ahinoam Lev-Sagie, Ilana Fox-Fisher, Sheina Piyanzin, Joshua Moss, Benjamin Glaser, Ruth Shemer, Yuval Dor
Journal: Blood
Blood (2022) 140 (Supplement 1): 1574–1575.
https://doi.org/10.1182/blood-2022-156740
Published: 2022